A nonsense mutation in the fibrillin-1 gene of a Marfan syndrome patient induces NMD and disrupts an exonic splicing enhancer.

A nonsense mutation in the fibrillin-1 (FBN1) gene of a Marfan syndrome (MFS) patient induces in-frame exon skipping of FBN1 exon 51. We present evidence, based on both in vivo and in vitro experiments, that the skipping of this exon is due to the disruption of an SC35-dependent splicing enhancer within exon 51. In addition, this nonsense mutation induces nonsense-mediated decay (NMD), which degrades the normally spliced mRNA in the patient's cells. In contrast to NMD, skipping of FBN1 exon 51 does not require translation.

[1]  A. Kornblihtt,et al.  A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. , 1993, Genes & development.

[2]  Tom Maniatis,et al.  Selection and Characterization of Pre-mRNA Splicing Enhancers: Identification of Novel SR Protein-Specific Enhancer Sequences , 1999, Molecular and Cellular Biology.

[3]  T. Maniatis,et al.  A systematic analysis of the factors that determine the strength of pre‐mRNA splicing enhancers , 1998, The EMBO journal.

[4]  M. Carter,et al.  A Regulatory Mechanism That Detects Premature Nonsense Codons in T-cell Receptor Transcripts in Vivo Is Reversed by Protein Synthesis Inhibitors in Vitro* , 1995, The Journal of Biological Chemistry.

[5]  H. Dietz,et al.  Maintenance of an open reading frame as an additional level of scrutiny during splice site selection , 1994, Nature Genetics.

[6]  T. Maniatis,et al.  A splicing enhancer exhibits both constitutive and regulated activities. , 1994, Genes & development.

[7]  S. Peltz,et al.  Nonsense-mediated mRNA decay in yeast. , 1994, Progress in nucleic acid research and molecular biology.

[8]  Michael Q. Zhang,et al.  Exonic Splicing Enhancer Motif Recognized by Human SC35 under Splicing Conditions , 2000, Molecular and Cellular Biology.

[9]  U. Francke,et al.  Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome , 1997, Nature Genetics.

[10]  M. Hentze,et al.  A Perfect Message RNA Surveillance and Nonsense-Mediated Decay , 1999, Cell.

[11]  A. Zahler.  Purification of SR protein splicing factors. , 1999, Methods in molecular biology.

[12]  J. Valcárcel,et al.  The SR protein family: pleiotropic functions in pre-mRNA splicing. , 1996, Trends in biochemical sciences.

[13]  L. Maquat.  When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. , 1995, RNA.

[14]  T. Cooper,et al.  The regulation of splice-site selection, and its role in human disease. , 1997, American journal of human genetics.

[15]  J. Mendell,et al.  When the Message Goes Awry Disease-Producing Mutations that Influence mRNA Content and Performance , 2001, Cell.

[16]  Y. Takeshima,et al.  Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy. , 1997, The Journal of clinical investigation.

[17]  B. Graveley.  Sorting out the complexity of SR protein functions. , 2000, RNA.

[18]  A. Zahler,et al.  Distinct functions of SR proteins in alternative pre-mRNA splicing. , 1993, Science.

[19]  L. Maquat,et al.  Quality Control of mRNA Function , 2001, Cell.

[20]  U. Francke,et al.  Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome. , 1996, Human molecular genetics.

[21]  K. Beemon,et al.  Nonsense codons within the Rous sarcoma virus gag gene decrease the stability of unspliced viral RNA. , 1991, Molecular and cellular biology.

[22]  M. Willing,et al.  Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains. , 1996, American journal of human genetics.

[23]  R. Pyeritz.  The Marfan syndrome. , 1986, American family physician.

[24]  A. Krainer,et al.  Preparation of HeLa cell nuclear and cytosolic S100 extracts for in vitro splicing. , 1999, Methods in molecular biology.

[25]  A. Shyu,et al.  Multifunctional regulatory proteins that control gene expression in both the nucleus and the cytoplasm , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[26]  David Valle,et al.  The skipping of constitutive exons in vivo induced by nonsense mutations , 1993, Science.

[27]  E. Puffenberger,et al.  Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. , 1992, The Journal of clinical investigation.

[28]  S. Peltz,et al.  The cap-to-tail guide to mRNA turnover , 2001, Nature Reviews Molecular Cell Biology.

[29]  A. Zahler,et al.  A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer , 1995, Molecular and cellular biology.

[30]  T. Maniatis,et al.  Positive control of pre-mRNA splicing in vitro. , 1992, Science.

[31]  H. Dietz.  Nonsense mutations and altered splice-site selection. , 1997, American journal of human genetics.

[32]  C. R. Valentine,et al.  The association of nonsense codons with exon skipping. , 1998, Mutation research.

[33]  Y. Shimura,et al.  The role of exon sequences in splice site selection. , 1993, Genes & development.

[34]  A. Krainer,et al.  Functional expression of cloned human splicing factor SF2: homology to rna-binding proteins, U1 70K, and drosophila splicing regulators , 1991, Cell.